Evine Appoints Senior Vice President, Chief Human Resources Officer
Dec 02, 2016 11:00 am UTC| Business
MINNEAPOLIS, Dec. 02, 2016 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV) a multiplatform video commerce company (evine.com), today announced the appointment of Lori Riley as Senior Vice President, Chief Human Resources...
Ingenico ePayments Reports Record Breaking Online Sales during Black Friday Weekend
Dec 02, 2016 10:00 am UTC| Business
AMSTERDAM, The Netherlands, Dec. 02, 2016 -- Ingenico ePayments, the online and mobile division of Ingenico Group, today reported that it processed 29% more payments during this year's Black Friday weekend compared to...
GlobalWafers Successfully Consummates Acquisition of SunEdison Semiconductor
Dec 02, 2016 09:36 am UTC| Business
HSINCHU, Taiwan, Dec. 02, 2016 -- GlobalWafers Co., Ltd. (TPEx:6488) (“GlobalWafers”) is pleased to announce that the acquisition of SunEdison Semiconductor Limited (“SunEdison Semiconductor”) by GlobalWafers has been...
Dec 02, 2016 07:18 am UTC| Business
Sarasota, FL, Dec. 02, 2016 -- Zion Research has published a new report titled “Gynecological Devices Market by Surgical Device (Gynecological Endoscopy Devices, Endometrial Ablation Devices, Fluid Management Systems...
Dec 02, 2016 07:16 am UTC| Business
STOCKHOLM, Sweden, Dec. 02, 2016 -- Karolinska Development AB (Nasdaq Stockholm:KDEV) today announces that its portfolio company Dilafor AB, a drug development company focusing on the development of tafoxiparin for...
Status of Repurchase of Own Shares of Internet Initiative Japan Inc.
Dec 02, 2016 07:03 am UTC| Business
TOKYO, Dec. 02, 2016 -- Internet Initiative Japan Inc. ("IIJ") (NASDAQ:IIJI) (TSE1:3774) announced today the status of the ongoing repurchase of its own shares as authorized at the meeting of IIJ’s Board of Directors...
Dec 02, 2016 06:22 am UTC| Business
Basel, Switzerland, Dec. 02, 2016 -- Basel, Switzerland, December 02, 2016 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the expansion of its ongoing oncology drug candidate BAL101553 clinical phase 1/2a oral...